Senna by PHARMACY VALUE ALLIANCE LLC / Geri-Care Pharmaceutical Corp pva 451B

Senna by

Drug Labeling and Warnings

Senna by is a Otc medication manufactured, distributed, or labeled by PHARMACY VALUE ALLIANCE LLC, Geri-Care Pharmaceutical Corp. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SENNA- sennosides tablet 
PHARMACY VALUE ALLIANCE LLC

----------

pva 451B

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

• relieves occasional constipation (irregularity)

• generally produces bowel movement in 6 to 12 hours

Warnings

Do not use

for more than one week unless directed by a doctor.

Ask a doctor before use if you
have stomach pain, nausea or vomiting
have noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

do not exceed 8 tablets in 24 hours

Age	Starting Dose	Maximum Dose
adults and children 12 years of age and older	2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor	4 tablets in the morning and 4 tablets at bedtime
children under 12 years	ask a doctor

Other information

• each tablet contains: calcium 30 mg
• Tamper Evident: Do not use if imprinted seal under cap is missing or broken
• store at 20°C-25°C (68°F-77°F)

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, silica, talc, triacetin

Package Label

SENNA 
sennosides tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 68016-832
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)
TALC (UNII: 7SEV7J4R1U)
TRIACETIN (UNII: XHX3C3X673)
HYPROMELLOSES (UNII: 3NXW29V3WO)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	PS23
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 68016-832-01	100 in 1 BOTTLE; Type 0: Not a Combination Product	12/01/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	12/01/2022	11/30/2025

Labeler - PHARMACY VALUE ALLIANCE LLC (101668460)

Registrant - Geri-Care Pharmaceutical Corp (611196254)

Revised: 11/2024

Document Id: 27feafe1-abde-8ed2-e063-6394a90aaa68

34390-5

Set id: 0a3502f3-f83d-0417-e063-6294a90a88a1

Version: 3

Effective Time: 20241128